RSS-Feed abonnieren

DOI: 10.1055/s-0042-1748837
A Clinical Risk Analysis of Postoperative Nausea and Vomiting After Colorectal Cancer Surgery
Authors
Funding None to declare.

Abstract
Objective Postoperative nausea and vomiting (PONV) is a frequent complication following colorectal surgery. The present study investigated the risk factors for PONV after colorectal cancer surgery.
Methods A retrospective study of 204 patients who underwent surgery for colorectal cancer was conducted. Univariate and multivariate analyses were performed to determine the clinicopathological factors associated with PONV.
Results The overall incidence of postoperative nausea (PON) and postoperative vomit (POV) was 26.5% (54/204), and 12.3% (25/204), respectively. The univariate analysis showed that female gender (p < 0.001), no current alcohol drinking habit (p = 0.003), and no stoma creation (p = 0.023) were associated with PON. Postoperative vomit was significantly correlated with female gender (p = 0.009), high body mass index (p = 0.017), and right-sided colon cancer (p = 0.001). The multivariate logistic regression analysis revealed that female gender (odds ratio [OR]: 4.225; 95% confidence interval [CI]: 2.170–8.226; p < 0.001) was an independent risk factor for PON. A high body mass index (OR: 1.148; 95%CI: 1.018–1.295; p = 0.025), and right-sided colon cancer (OR: 3.337; 95%CI: 1.287–8.652; p = 0.013) were independent risk factors for POV.
Conclusion Our findings suggest that female gender for PON and a high body mass index and right-sided colon cancer for POV are risk factors after colorectal cancer surgery. An assessment using these factors might be helpful for predicting PONV.
Ethics Approval
The medical ethics committee of Saga Medical Center Koseikan reviewed and approved the present study design (permission number: 21-03-01-05).
Consent to Participate
All patients and their families were informed about the surgical procedure and provided their written consent. Broad consent for this study was obtained.
Consent for Publication
Broad consent was obtained for the present study.
Availability of Data and Material
The data sets generated during the present study are available from the corresponding author on reasonable request.
Author Contributions
Hiraki M., Koga M. and Miura D. designed the present study. Hiraki M., Tanaka T., Koga M., Miura D., Sato H., Mitsumizo S., and Kitahara K. treated the patients. Hiraki M. and Sadashima E. (specialist in statistics) analyzed the data. Hiraki M., Tanaka T., Koga M. and Miura D. interpreted the results and wrote the manuscript.
Publikationsverlauf
Eingereicht: 07. Dezember 2021
Angenommen: 03. März 2022
Artikel online veröffentlicht:
21. Juli 2022
© 2022. Sociedade Brasileira de Coloproctologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 Virlos I, Clements D, Beynon J, Ratnalikar V, Khot U. Short-term outcomes with intrathecal versus epidural analgesia in laparoscopic colorectal surgery. Br J Surg 2010; 97 (09) 1401-1406
- 2 Choi YY, Park JS, Park SY. et al. Can intravenous patient-controlled analgesia be omitted in patients undergoing laparoscopic surgery for colorectal cancer?. Ann Surg Treat Res 2015; 88 (02) 86-91
- 3 Lee SH, Sim WS, Kim GE. et al. Randomized trial of subfascial infusion of ropivacaine for early recovery in laparoscopic colorectal cancer surgery. Korean J Anesthesiol 2016; 69 (06) 604-613
- 4 Park HE, Kim MK, Kang WK. Efficacy and Safety of Ramosetron Injection for Nausea and Vomiting in Colorectal-Cancer Patients Undergoing a Laparoscopic Colectomy: A Randomized, Double-Blind, Comparative Study. Ann Coloproctol 2018; 34 (01) 36-41
- 5 Mc Loughlin S, Terrasa SA, Ljungqvist O, Sanchez G, Garcia Fornari G, Alvarez AO. Nausea and vomiting in a colorectal ERAS program: Impact on nutritional recovery and the length of hospital stay. Clin Nutr ESPEN 2019; 34: 73-80
- 6 Holder-Murray J, Esper SA, Boisen ML. et al. Postoperative nausea and vomiting in patients undergoing colorectal surgery within an institutional enhanced recovery after surgery protocol: comparison of two prophylactic antiemetic regimens. Korean J Anesthesiol 2019; 72 (04) 344-350
- 7 Hill RP, Lubarsky DA, Phillips-Bute B. et al. Cost-effectiveness of prophylactic antiemetic therapy with ondansetron, droperidol, or placebo. Anesthesiology 2000; 92 (04) 958-967
- 8 Pierre S, Whelan R. Nausea and vomiting after surgery. Contin Educ Anaesth Crit Care Pain 2012; 13: 28-32
- 9 Parra-Sanchez I, Abdallah R, You J. et al. A time-motion economic analysis of postoperative nausea and vomiting in ambulatory surgery. Can J Anaesth 2012; 59 (04) 366-375
- 10 Cienfuegos JA, Baixauli J, Arredondo J. et al. Clinico-pathological and oncological differences between right and left-sided colon cancer (stages I-III): analysis of 950 cases. Rev Esp Enferm Dig 2018; 110 (03) 138-144
- 11 Masoomi H, Buchberg B, Dang P, Carmichael JC, Mills S, Stamos MJ. Outcomes of right vs. left colectomy for colon cancer. J Gastrointest Surg 2011; 15 (11) 2023-2028
- 12 Gan TJ, Belani KG, Bergese S. et al. Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting. Anesth Analg 2020; 131 (02) 411-448
- 13 Apfel CC, Heidrich FM, Jukar-Rao S. et al. Evidence-based analysis of risk factors for postoperative nausea and vomiting. Br J Anaesth 2012; 109 (05) 742-753
- 14 Watcha MF, White PF. Postoperative nausea and vomiting. Its etiology, treatment, and prevention. Anesthesiology 1992; 77 (01) 162-184
- 15 Cohen MM, Duncan PG, DeBoer DP, Tweed WA. The postoperative interview: assessing risk factors for nausea and vomiting. Anesth Analg 1994; 78 (01) 7-16
- 16 Lambert DM, Marceau S, Forse RA. Intra-abdominal pressure in the morbidly obese. Obes Surg 2005; 15 (09) 1225-1232
- 17 Walder AD, Aitkenhead AR. Antiemetic efficacy of metoclopramide when included in a patient-controlled analgesia infusion. Anaesthesia 1994; 49 (09) 804-806
- 18 Alexander R, Lovell AT, Seingry D, Jones RM. Comparison of ondansetron and droperidol in reducing postoperative nausea and vomiting associated with patient-controlled analgesia. Anaesthesia 1995; 50 (12) 1086-1088
- 19 Dresner M, Dean S, Lumb A, Bellamy M. High-dose ondansetron regimen vs droperidol for morphine patient-controlled analgesia. Br J Anaesth 1998; 81 (03) 384-386
- 20 Weibel S, Schaefer MS, Raj D. et al. Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: an abridged Cochrane network meta-analysis(‡§). Anaesthesia 2020
- 21 Gan TJ, Diemunsch P, Habib AS. et al; Society for Ambulatory Anesthesia. Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg 2014; 118 (01) 85-113